- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.01. | Lilly's Omvoh approved by FDA for Crohn's | ||
| 16.01. | JPM25: The FDA's future, AbbVie's second thoughts and Lilly's lesson | ||
| 15.01. | At JPM, Biogen CEO tries to take down the deal temperature | ||
| 15.01. | J&J files a potential blockbuster; Lykos shakes up its board | ||
| 15.01. | Federal watchdog cites concerns with FDA's accelerated approval process | ||
| 15.01. | JPM25: Amgen's defense, Merck's patent 'hill' and Viking Therapeutics' long-term planning | ||
| 14.01. | Lilly blames slower-than-expected growth for 2024 sales miss | ||
| 14.01. | Regenxbio licenses gene therapies to Japan's Nippon Shinyaku | ||
| 14.01. | 5 questions facing emerging biotech in 2025 | ||
| 13.01. | JPM25: Deals, Summit's bravado and gene therapy headwinds | ||
| 13.01. | Biogen's 'cold and calculated' offer to buy Sage receives a mixed reaction on Wall Street | ||
| 13.01. | Moderna shares tumble on slashed sales guidance | ||
| 13.01. | Lilly pads cancer drug pipeline with Scorpion deal | ||
| 13.01. | J&J to buy psychiatric drug developer Intra-Cellular for $14.6B | ||
| 13.01. | Lack of regulatory harmonization and other challenges facing clinical services organizations in the APAC market | ||
| 13.01. | Tune raises $175M for hepatitis B medicine, epigenetic research | ||
| 10.01. | Pfizer's PD-1 drug succeeds; AbbVie writes down $3.5B in Cerevel assets | ||
| 10.01. | Patrizia Cavazzoni, key FDA official, to leave agency | ||
| 10.01. | Intellia to stop work on rare disease therapy, lay off staff | ||
| 10.01. | Ouro, backed by GSK, joins hunt to bring bispecifics to autoimmune disease | ||
| 09.01. | IGM's autoimmune pivot backfires as top drug disappoints in testing | ||
| 09.01. | 5 questions facing pharma in 2025 | ||
| 09.01. | Bayer says menopause drug succeeds in breast cancer study | ||
| 09.01. | Healthcare venture capital investment boosted by AI in 2024: report | ||
| 09.01. | Verdiva starts up with $411M and a portfolio of obesity drugs from China |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
